Now at Present
Singapore Nifty +36.5 point
43.1460 INR = $
Crude = 138.7 $
MARKET, IS HAVING NEGATIVE SENTIMENT AND CAN LOOK TO TEST 3780,PANIC IN THE MARKET AND THE NIFTY CAN GO DOWN TO 3780 AND BREAK OF THIS THEN 3710 WILL SHOW UP ON YOUR SCREEN
ON THE UPSIDE NIFTY IS LIKELY TO FACE HURDLE AT 3890 AND THEN UPON CROSSOVER OF 3890 NIFTY WILL FACE NEXT RESISTANCE AT 3955-60
IMPORTANT DATES TO BE WATCHED.
o JULY 16 - EIA PETROLEUM REPORT
o JULY 22 - VOTE OF CONFIDENCE AGAINST UPA GOVT.
o JULY 29 - RBI MEET
TRADING STRATEGY - AT THE MOMENT MARKET SEEMS TO BE DIRECTIONLESS MORE ON THE NEGATIVE SIDE. NIFTY SPOT TRADING RANGE 3780 – 3890. BREAK OF ANY SIDE WILL CATCH THE MOMENTUM ON THAT SIDE
Parsvanath could see some short term gains as the company is set to make some announcement later in the day
IFCI bounced back from its intra-day low, the stock gained by a percent to close at Rs37. The company is planning to buy non-performing assets (NPAs) of the IIBI Ltd, according to a report also plans to revive these assets and recover money from them to add to its net profit. The scrip touched an intra-day high of Rs38.5 and a low of Rs35 and recorded volumes of over 1,00,00,000 shares on BSE
Indian Markets might close in the positive zone
JGS Investments is a home of expert stockmarket analysts, and premier source for technical analysts research and information on Indian Stock Markets.Just join us at Yahoo Messenger sheth_jg@yahoo.com OR Email at sheth_jg@yahoo.com
Wednesday, July 16, 2008
Tuesday, July 15, 2008
Bulls and Bears are Playing,Subscribe to know who wins
Our Trading Call of SAURASHTRA CEMENT, Flared and Hit 20% UPPER-FILTER
Our Trading Call of Ranbaxy, Also Flared Almost 11% , and Complete's IT'S Days Target
Nifty (4040) Sup 3920 Res 4100
Sell HDFC (1934) SL 1960
Target 1885, 1875
Ranbaxy may see some recovery after the company clarified that its deal with Daiichi is on track. Earlier reports stated production at three facilities of Ranbaxy Laboratories could be banned if charges of fraud, forging of documents and manufacturing from unapproved locations leveled by USFDA are proved
Some buying may be seen in mid cap counters. HUL could be among the safer stocks for the time being.
Steel companies could see some action on reports that they are considering 15% hike in prices to offset rising raw material costs. Meanwhile, the railways has reportedly decided to give a 25% discount on domestic iron ore freight booked to ports in a bid to help steel companies.
Among the major bulk deals, Merrill Lynch sold 200,000 shares of Selan Exploration at an average price of Rs217.
Insider trades:
Sakthi Sugars: M.Manickam, Vice Chairman & Managing Director of the company from the market has purchased 10,499 equity shares on 10th July 2008.
Gateway Distriparks: Kirpa Ram Vij, Director of the company has purchased 15,000 shares from the open market on 9th July 2008.
Our Trading Call of Ranbaxy, Also Flared Almost 11% , and Complete's IT'S Days Target
Nifty (4040) Sup 3920 Res 4100
Sell HDFC (1934) SL 1960
Target 1885, 1875
Ranbaxy may see some recovery after the company clarified that its deal with Daiichi is on track. Earlier reports stated production at three facilities of Ranbaxy Laboratories could be banned if charges of fraud, forging of documents and manufacturing from unapproved locations leveled by USFDA are proved
Some buying may be seen in mid cap counters. HUL could be among the safer stocks for the time being.
Steel companies could see some action on reports that they are considering 15% hike in prices to offset rising raw material costs. Meanwhile, the railways has reportedly decided to give a 25% discount on domestic iron ore freight booked to ports in a bid to help steel companies.
Among the major bulk deals, Merrill Lynch sold 200,000 shares of Selan Exploration at an average price of Rs217.
Insider trades:
Sakthi Sugars: M.Manickam, Vice Chairman & Managing Director of the company from the market has purchased 10,499 equity shares on 10th July 2008.
Gateway Distriparks: Kirpa Ram Vij, Director of the company has purchased 15,000 shares from the open market on 9th July 2008.
Monday, July 14, 2008
This week how to trade with markets
Nifty Futures
Buy Nifty July Futures @ 3920-3930* Stop Loss: 3850* Target:
4180-4200* (*Spot levels)
Nifty Strategy
Sell One Nifty July 3800 PE @ 74-78; Sell One July 4200 CE @
66-70; UBEP:4340; LBEP: 3660; SL: 185 (total premium); TF:
8-10 days
Pair strategy
Buy Tata Motors and Sell M&M
Buy one lot TataMotor July Fut @ 392-395 and Sell one lot M&M
July Fut @ 525-530. Time Frame: 10-12 Days.
Buy PNB and Sell Allahabad Bank
Buy two lot ALBK July Fut @ 57-58 and Sell one lot PNB July
Fut @ 392-394. Time Frame: 10-12 Days.
Hybrid strategy
Covered Call in Reliance
Buy 1 lot Reliance July Fut @ 2028-2030 and Sell 1 July 2160 CA
@ 28-30. BEP: 2000. Stop Loss: 1980. Time Frame: 10-12 days
Buy Nifty July Futures @ 3920-3930* Stop Loss: 3850* Target:
4180-4200* (*Spot levels)
Nifty Strategy
Sell One Nifty July 3800 PE @ 74-78; Sell One July 4200 CE @
66-70; UBEP:4340; LBEP: 3660; SL: 185 (total premium); TF:
8-10 days
Pair strategy
Buy Tata Motors and Sell M&M
Buy one lot TataMotor July Fut @ 392-395 and Sell one lot M&M
July Fut @ 525-530. Time Frame: 10-12 Days.
Buy PNB and Sell Allahabad Bank
Buy two lot ALBK July Fut @ 57-58 and Sell one lot PNB July
Fut @ 392-394. Time Frame: 10-12 Days.
Hybrid strategy
Covered Call in Reliance
Buy 1 lot Reliance July Fut @ 2028-2030 and Sell 1 July 2160 CA
@ 28-30. BEP: 2000. Stop Loss: 1980. Time Frame: 10-12 days
Trading Calls - July 14 2008
Rel Com can be bought around 435 with a stop loss of 428. The stock may be a slow starter but could be a surprise package. Above 444 it will show strength
Market Grape Wine :
In House :
Nifty at a support of 3995 and 3935 levels with resistance at 4115 and 4165 levels .
Buy : in F&O Tisco above 644 target 665 s/l fo 635
Sell : in F&O Centextile below 490 target 465 s/l of 505
Out House:
Markets at a support of 13456 & 13232 resistance at 13786 & 13636 levels .
Buy : Sail & Tsico
Buy : Sbin at dips
Buy : ITC at dips
Buy : Bhel & LT at dips
Buy : ACC
Buy : RIL
Buy : Titan at dips
Dark Horse : Sbin , LT , RIL , Suzlon & Tisco
Market Grape Wine :
In House :
Nifty at a support of 3995 and 3935 levels with resistance at 4115 and 4165 levels .
Buy : in F&O Tisco above 644 target 665 s/l fo 635
Sell : in F&O Centextile below 490 target 465 s/l of 505
Out House:
Markets at a support of 13456 & 13232 resistance at 13786 & 13636 levels .
Buy : Sail & Tsico
Buy : Sbin at dips
Buy : ITC at dips
Buy : Bhel & LT at dips
Buy : ACC
Buy : RIL
Buy : Titan at dips
Dark Horse : Sbin , LT , RIL , Suzlon & Tisco
Friday, July 11, 2008
Close above 14000 ,Partytime
Cairn our pick
Infosys result as mention earlier to clients are better than expected
For more visit
http://www.freewebs.com/jgs-investments/marketwhisper.htm
Infosys result as mention earlier to clients are better than expected
For more visit
http://www.freewebs.com/jgs-investments/marketwhisper.htm
Thursday, July 10, 2008
Market may remain cautious
Now at Present
Singapore Nifty -43.0 point
43.2170 INR = $
Crude = 136.57 $
Yesterday's Rally
Led By ???
SHORT COVERING
or
Technical Pull Back
or
Rally in Bear Market
or
Something Else
Soon this site will go paid
For membership pls contact sheth_jg@yahoo.com
I have an Ideaaaaaaaaaaa
Singapore Nifty -43.0 point
43.2170 INR = $
Crude = 136.57 $
Yesterday's Rally
Led By ???
SHORT COVERING
or
Technical Pull Back
or
Rally in Bear Market
or
Something Else
Soon this site will go paid
For membership pls contact sheth_jg@yahoo.com
I have an Ideaaaaaaaaaaa
Wednesday, July 9, 2008
BUY R-pack today
We expect a positive opening. What is not certain is whether the gains can be extended further. Fresh bad news can hit the markets anytime and reverse most of the gains.
One Can buy Banks like Kotak,icici,Banknifty
Today's Pick - GSK Pharma
We recommend a buy in GlaxoSmithKline Pharmaceuticals from a short-term horizon. It is clearly visible from the charts of GlaxoSmithKline Pharmaceuticals that it was on a long-term down trend from its April 2006 high of Rs 1,553 to its January 2008 low of Rs 704. However, the stock reversed direction in January and has been on a steady uptrend since then. We notice an inverse complex head and shoulders pattern, spanning over the past nine months with neckline at Rs 1,150. On July 8, the stock decisively broke out of the neckline by surging more than 3 per cent, accompanied with above 2 week average volume. The stock is trading well above its 21 and 50-day moving averages. The daily and weekly momentum indicators are featuring in the bullish zone. The daily moving average convergence and divergence (MACD) is featuring in the positive territory and the weekly MACD has entered this territory. Besides, the up trendline of the stock is intact. Our short-term forecast for the stock is bullish and we expect it to rally until it hits our price target of Rs 1,300 in the forthcoming trading sessions. Traders with short-term perspective can buy the stock while maintaining stop-loss at Rs 1,125
Results today:
Bajaj Auto Finance, Bajaj Finserv and Prithvi Information
New Listing:
TTT Rohan Mehta: New Listing:
Chakkilam Infotech; no circuit filter today ((currently listed on Bangalore SE))
One Can buy Banks like Kotak,icici,Banknifty
Today's Pick - GSK Pharma
We recommend a buy in GlaxoSmithKline Pharmaceuticals from a short-term horizon. It is clearly visible from the charts of GlaxoSmithKline Pharmaceuticals that it was on a long-term down trend from its April 2006 high of Rs 1,553 to its January 2008 low of Rs 704. However, the stock reversed direction in January and has been on a steady uptrend since then. We notice an inverse complex head and shoulders pattern, spanning over the past nine months with neckline at Rs 1,150. On July 8, the stock decisively broke out of the neckline by surging more than 3 per cent, accompanied with above 2 week average volume. The stock is trading well above its 21 and 50-day moving averages. The daily and weekly momentum indicators are featuring in the bullish zone. The daily moving average convergence and divergence (MACD) is featuring in the positive territory and the weekly MACD has entered this territory. Besides, the up trendline of the stock is intact. Our short-term forecast for the stock is bullish and we expect it to rally until it hits our price target of Rs 1,300 in the forthcoming trading sessions. Traders with short-term perspective can buy the stock while maintaining stop-loss at Rs 1,125
Results today:
Bajaj Auto Finance, Bajaj Finserv and Prithvi Information
New Listing:
TTT Rohan Mehta: New Listing:
Chakkilam Infotech; no circuit filter today ((currently listed on Bangalore SE))
Subscribe to:
Posts (Atom)